Keppra and Nucynta er drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Keppra (levetiracetam) and Nucynta er (tapentadol hydrochloride). Common drug interactions include confusional state among females and apraxia among males.
The phase IV clinical study analyzes what interactions people have when they take Keppra and Nucynta er. It is created by eHealthMe based on reports of 13 people who take the same drugs from the FDA, and is updated regularly.
What is Keppra?
Keppra has active ingredients of levetiracetam. It is often used in epilepsy. eHealthMe is studying from 73,504 Keppra users. Check the latest studies of Keppra.
What is Nucynta er?
Nucynta er has active ingredients of tapentadol hydrochloride. It is often used in pain. eHealthMe is studying from 2,508 Nucynta er users. Check the latest studies of Nucynta er.
13 people who take Keppra and Nucynta er together, and have interactions are studied.

What are the common drug interactions of Keppra and Nucynta Er, by gender? *:
female:
- Confusional state
- Depressed level of consciousness
- Depression
- Drug ineffective
- Dysphonia (speech disorder attributable to a disorder of phonation)
- Gait disturbance
- Memory impairment
- Seasonal allergy (allergic condition due to certain season)
- Serotonin syndrome (occurs when two drugs that affect the body's level of serotonin are taken together at the same time)
- Tooth extraction
male:
- Apraxia (disorder that affects a person's ability to organize the movements of the muscles used in speech)
- Dysarthria (speech disorder)
- Gait disturbance
- Hypertensive crisis
- Personality change
What are the common drug interactions of Keppra and Nucynta Er, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
n/a
30-39:
n/a
40-49:
- Confusional state
- Depressed level of consciousness
- Serotonin syndrome (occurs when two drugs that affect the body's level of serotonin are taken together at the same time)
- Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
- Drug hypersensitivity
50-59:
n/a
60+:
- Gait disturbance
- Amnesia (deficit in memory caused by brain damage, disease, or psychological trauma)
- Seasonal allergy (allergic condition due to certain season)
- Tooth extraction
- Urinary incontinence (inability to control the flow of urine and involuntary urination)
- Urinary tract infection
- Weight decreased
- Asthenia (weakness)
- Cognitive disorder (mental health disorders affects learning, memory, perception, and problem solving)
- Dysstasia (difficulty in standing)
What are the existing conditions these people have? *
- Constipation: 6 people, 46.15%
- Seizures (abnormal excessive or synchronous neuronal activity in the brain): 4 people, 30.77%
- Wheezing (a high-pitched whistling sound made while you breath): 3 people, 23.08%
- Pain In Extremity: 3 people, 23.08%
- Arthritis (form of joint disorder that involves inflammation of one or more joints): 3 people, 23.08%
- Fatigue (feeling of tiredness): 3 people, 23.08%
- Flatulence (flatus expelled through the anus): 3 people, 23.08%
- Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 3 people, 23.08%
- Tremor (trembling or shaking movements in one or more parts of your body): 3 people, 23.08%
- Muscle Spasms (muscle contraction): 3 people, 23.08%
* Approximation only. Some reports may have incomplete information.
Do you take Keppra and Nucynta er?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
- Keppra (73,504 reports)
- Nucynta er (2,508 reports)
Browse all drug interactions of Keppra and Nucynta er:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Keppra:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Nucynta er:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Keppra and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Nucynta er and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zRelated publications that referenced our studies
- Schattner A, Al-Bewerat A, "Levetiracetam (Keppra), urinary retention and literature search", A fatty cause of renal failure; what is your diagnosis?, 2016 Oct .
- Spengler DC, Montouris GD, Hohler AD, "Levetiracetam as a possible contributor to acute kidney injury", Clinical therapeutics, 2014 Aug .
- Almeida DM, Jean MR, Chystsiakova A, Monahan E, Oliveira SB, Monteiro IM, "Levetiracetam-associated acute pancreatitis in an adolescent with autism: a case report", Pancreas, 2013 Jan .
- Schattner A, Al-Bewerat A, "Levetiracetam (Keppra), urinary retention and literature search", A fatty cause of renal failure; what is your diagnosis?, 2016 Oct .
- Spengler DC, Montouris GD, Hohler AD, "Levetiracetam as a possible contributor to acute kidney injury", Clinical therapeutics, 2014 Aug .
- Almeida DM, Jean MR, Chystsiakova A, Monahan E, Oliveira SB, Monteiro IM, "Levetiracetam-associated acute pancreatitis in an adolescent with autism: a case report", Pancreas, 2013 Jan .
How the study uses the data?
The study uses data from the FDA. It is based on levetiracetam and tapentadol hydrochloride (the active ingredients of Keppra and Nucynta er, respectively), and Keppra and Nucynta er (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Haemorrhage and High Blood Pressure - 5 seconds ago
- Drug interactions of Atacand and Lidoderm - 6 seconds ago
- Drug interactions of Fluoxetine and Ziac - 7 seconds ago
- Could Implanon cause Hypotension? - 10 seconds ago
- Could Alavert cause Hypercholesterolaemia Aggravated? - 10 seconds ago
- Could Wellbutrin cause Tachyphrenia? - 12 seconds ago
- Could Adalat cause Multiple Myeloma? - 13 seconds ago
- Could Opdivo cause Cholecystitis? - 13 seconds ago
- Could Tasigna cause Iron Deficiency Anaemia? - 21 seconds ago
- Could Maxalt cause Depression Aggravated? - 22 seconds ago